Trial Profile
Phase II exemestane versus paclitaxel as first-line treatment of patients with metastatic hormone receptor positive breast cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2017
Price :
$35
*
At a glance
- Drugs Exemestane (Primary) ; Paclitaxel
- Indications Adenocarcinoma; Breast cancer
- Focus Therapeutic Use
- 19 Jan 2017 New trial record